FDA proposal to restrict compounded GLP-1 medicines raises safety concerns for pharmacists

Pharmacists express heightened concerns over the safety, authenticity, and regulation of compounded GLP-1 medicines as the FDA moves towards tighter rules amid rising demand and market complexities. Pharmacists are increasingly being asked to help patients navigate a fast-changing market for…













